SCHEMBL13500644

SCHEMBL13500644

COC(=O)c1cc(F)c2ccn(C(=O)OC)c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.41
▸ KMT2A Q03164 4/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ KDM4E B2RXH2 4/20 0.40
▸ LMNA P02545 3/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ NFKB1 P19838 2/20 0.40
▸ NFKB2 Q00653 2/20 0.40
▸ RELA Q04206 2/20 0.40
▸ XDH P47989 2/20 0.40
▸ GAA P10253 1/20 0.40
▸ GFER P55789 1/20 0.40
▸ FUT7 Q11130 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ CA12 O43570 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13500645 0.83 KDM4E (0.45) POLBKMT2AMEN1KDM4ELMNA
SCHEMBL13500647 0.83 ALDH1A1 (0.41) POLBKMT2AMEN1KDM4ELMNA
SCHEMBL15232028 0.75 KDM4E (0.53) POLBKMT2AMEN1KDM4ELMNA
SCHEMBL18052988 0.74 PTGER4 (0.35) KMT2AMEN1
SCHEMBL19477032 0.72 HDAC1 (0.37) KMT2AMEN1L3MBTL1CYP1A2CYP2C19
SCHEMBL17113072 0.72 UCHL1 (0.41) POLBKDM4ELMNAL3MBTL1GAA
SCHEMBL20224068 0.70 KMT2A (0.32) KMT2AMEN1
SCHEMBL14002933 0.70 LPO (0.48) KMT2AMEN1KDM4EL3MBTL1ALDH1A1
SCHEMBL1096952 0.69 KDM4E (0.59) POLBKMT2AMEN1KDM4ELMNA
SCHEMBL18052948 0.68 MEN1 (0.39) KMT2AMEN1KDM4ELMNAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7662824-B2 Acylhydrazones as kinase modulators JANSSEN PHARMACEUTICA NV (BE) 2010-02-16 — — US disclosed
US-7662824-B2 Acylhydrazones as kinase modulators JANSSEN PHARMACEUTICA NV (BE) 2010-02-16 — — US disclosed
US-20070066610-A1 Acylhydrazones as kinase modulators JANSSEN PHARMACEUTICAL, N.V. (BE) 2007-03-22 — — US disclosed
US-20070066610-A1 Acylhydrazones as kinase modulators JANSSEN PHARMACEUTICAL, N.V. (BE) 2007-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070066610-A1 Acylhydrazones as kinase modulators MET, ERBB2, ERBB3 POLB 4309/4885KMT2A 471/4885MEN1 718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback